Peptide Technologies
Semaglutide
Finnrick tested 4 samples of Semaglutide (GLP-1 antagonist) from Peptide Technologies between 27 Feb 2025 and 20 Mar 2025. Tests score average over 7, no score below 6, and at least 2 tests warrant a tentative Finnrick Rating of A (Great).
Finnrick Rating™
Peptide Technologies
Semaglutide
Tested 4 Samples
Last test 20 Mar 2025
Take Action
Mail in a Sample
We test your peptides for free: mail in a sample you have (US only), or request us to test a vendor.
Semaglutide is also available from top-rated vendors:
All Semaglutide tests from Peptide Technologies
Samples are tested in commercial labs
Tests Count
4
Scores
AVGMINMAX
Last
20 Mar 2025
First
27 Feb 2025
| Quantity | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Test Date | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 20 Mar 2025 | 5mg | 5.050mg | +1.0% | 99.97% | 394903 | White Label / White Cap | Lab B | Finnrick | |
| 28 Feb 2025 | 5mg | 5.458mg | +9.2% | 99.81% | 394903 | White Label / White Cap | Lab C | Finnrick | |
| 28 Feb 2025 | 5mg | 5.670mg | +13.4% | 99.64% | 394903 | White Label / White Cap | Lab C | Finnrick | |
| 27 Feb 2025 | 5mg | 5.063mg | +1.3% | 99.74% | 394903 | White Label / White Cap | Lab A | Finnrick | |